Study on the Application of Intraoperative Optical Coherence Tomography Technique in the Diagnosis and Treatment of Lens Diseases

NCT06687356 · tracked via the Priya Life Science China tracker

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Phase

Not applicable

Started

2024-11-27

Last updated

2025-05-22

Condition(s) studied

Lens Diseases

Investigational drug(s) / intervention(s)

Surgery with Intraoperative Optical Coherence Tomography applicationConventional surgery

Surgery with Intraoperative Optical Coherence Tomography application: Surgery with the application of intraoperative optical coherence tomography technique. Intraoperative optical coherence tomography technique can provide intraocular images and show changes in intraocular structures, assisting in analyzing the correlation between preoperative, intraoperative anterior segment structural changes and postoperative surgical effects in patients with lens diseases.

Conventional surgery: Conventional lens surgery, without the application of intraoperative optical coherence tomography technique.

Study summary

Accurately assessing and dealing with anterior segment changes in the eyes of patients with lens diseases can better guide the operation details during surgery and make reasonable plans for possible intraoperative and postoperative complications. Applying the intraoperative optical coherence tomography technique, this study analyzes the correlation between preoperative, intraoperative anterior segment structural changes and postoperative surgical effects in patients with lens diseases, and evaluates the clinical benefits of intraoperative optical coherence tomography technique in lens surgery. This study is intended to further improve the diagnosis and treatment quality of clinical lens diseases.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients aged over 18 years old, with lens opacity or abnormal position, and other conditions meeting the surgical indications, needing lens surgery treatment, with or without anterior segment structural changes. Exclusion Criteria: * Combined with other eye diseases that seriously affect visual prognosis, serious systemic diseases and other conventional contraindications for lens surgery.

Primary outcome measure(s)

Successful implantation rate of intraocular lens — through study completion, an average of 1 year
Implantation rate of intraocular lens after surgery.
Intraocular lens position after implantation — 1day, 1 week and 1 month postoperation
The location of intraocular lens after surgery, observed through slit - lamp and anterior segment optical coherence tomography.

Trial sites (2)

Facility	City	Region	Status
Second Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	Zhejiang	Not Yet Recruiting
Second Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	Zhejiang	Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Microneedle Intra-Arterial Injection for Retinal Artery Occlusion Recruiting

Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease Recruiting

Multicenter Study on the Use of Intraoperative OCT in the Diagnosis and Management of Lens Diseases Active, not recruiting

China Longitudinal Aging and Cognitive Impairment Study Recruiting

Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients Starting soon

Other trials for the same condition

Multicenter Study on the Use of Intraoperative OCT in the Diagnosis and Management of Lens Diseases Active, not recruiting

Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities Recruiting

Full 3D Eye Modeling in the Diagnosis and Treatment of Lens Diseases With Eye Structures Disorders Recruiting

Study on the Application of Adaptive Fluidics Technology in Lens Diseases Surgery Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06687356 on ClinicalTrials.gov ↗ ← All trials in China